These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N. J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [Abstract] [Full Text] [Related]
14. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients. Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P. Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412 [Abstract] [Full Text] [Related]
15. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas. Kim SH, Ku CR, Na M, Yoo J, Kim W, Jung IH, Kim KW, Moon JH, Kim D, Lee EJ, Kim SH, Kim EH. J Neurosurg; 2021 Mar 01; 134(3):794-800. PubMed ID: 32168476 [Abstract] [Full Text] [Related]
17. Extended transsphenoidal approach for surgical management of pituitary adenomas invading the cavernous sinus. Kitano M, Taneda M, Shimono T, Nakao Y. J Neurosurg; 2008 Jan 01; 108(1):26-36. PubMed ID: 18173307 [Abstract] [Full Text] [Related]